MARK1 Polyclonal Antibody

Background:
MAP/microtubule affinity-regulating kinase 1 (MARK1) is a 795 amino acid protein belonging to the CAMK Ser/Thr protein kinase family. MARK1 is thought to play a role in the stability of the microtubule matrix of the cytoskeleton. MARK1 is activated by phosphorylation of Thr215 by LKB1 in complex with STRAD and MO25. Localized to the cytoskeleton, MARK1 contains one kinase-associated (KA1) domain, one protein kinase domain and one UBA domain. Expressed as three isoforms produced by alternative splicing, MARK1 is found with highest levels in brain, skeletal muscle and heart.

Research Area: Signal Transduction

Synonyms:
KIAA1477, MAP/microtubule affinity regulating kinase 1, MAP/microtubule affinity-regulating kinase 1, MARK 1, MARK, Mark1, MARK1, MGC126512, MGC126513, Serine/threonine protein kinase MARK1, Serine/threonine-protein kinase MARK1

Immunogen: Recombinant protein of human MARK1

Swissprot: Q9P0L2
Gene Accession: BC113869

Calculated MW: 89 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.3 mg/mL
Dilution: WB 1:500-1:2000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-70088/sc-70090/sc-130815